Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private

BSE1452.1594.9 (+6.99 %)

PREV CLOSE ( ) 1357.25

OPEN PRICE ( ) 1343.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 61553

TODAY'S LOW / HIGH ( )1343.25 1489.00

52 WK LOW / HIGH ( )1075 2249.65

NSE1447.10113 (+8.47 %)

PREV CLOSE( ) 1334.10

OPEN PRICE ( ) 1352.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1447.10 (985)

VOLUME 840018

TODAY'S LOW / HIGH( ) 1344.50 1467.50

52 WK LOW / HIGH ( )1057 2248

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Profit Before Tax

-677.56

-3911.65

-7998.30

-2311.60

Adjustment

4268.00

2880.84

6044.34

1474.20

Changes In working Capital

-4198.86

-41.30

217.00

-3321.46

Cash Flow after changes in Working Capital

-608.42

-1072.11

-1736.96

-4158.86

Cash Flow from Operating Activities

-678.54

-1072.11

-1627.65

-4158.86

Cash Flow from Investing Activities

-2010.81

5105.45

-678.34

-6916.04

Cash Flow from Financing Activities

4120.08

-3905.44

1183.18

11619.60

Net Cash Inflow / Outflow

1430.73

127.90

-1122.81

544.70

Opening Cash & Cash Equivalents

222.64

94.74

1217.55

672.85

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.22

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

1653.59

222.64

94.74

1217.55